|Bid||14.01 x 0|
|Ask||14.02 x 0|
|Day's Range||13.89 - 14.02|
|52 Week Range||11.66 - 16.57|
|Beta (3Y Monthly)||0.39|
|PE Ratio (TTM)||44.92|
|Forward Dividend & Yield||0.18 (1.32%)|
|1y Target Est||12.43|
ResMed Inc NYSE:RMDView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for RMD with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding RMD totaled $11.33 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Investorideas.com, a leading investor news resource covering technology and healthcare stocks releases a snapshot looking at how healthcare is changing in the digital age. Investorideas recently reported on how Digital Health technologies enabling out-of-hospital care and monitoring are forecast to grow by 30 percent and cross the $25 billion mark. In the article, Kamaljit Behera, Industry Analyst, Transformational Health, said, "In this highly digitized environment, artificial intelligence (AI) will permeate the life sciences ecosystem, and its use in healthcare IT (HIT) is likely to cross $1.7 billion by the end of 2019.
The Dow Jones Industrial Average rose 0.8% to close at 24,737.20 on a report that the Fed might stop winding down its bond holdings earlier than expected.
Stocks that moved substantially or traded heavily Friday: Western Digital Corp., up $3.02 to $43.16 The hard-drive maker reported better-than-expected quarterly financial results and an upbeat forecast. ...
The San Diego company reported a 9% increase in adjusted revenue to $651.1 million but lagged Wall Street's expectations of $667 million. "We had a solid quarter with top-line growth and gross margin expansion, as well as continued fiscal discipline to drive leverage and improved operating profit," said Mick Farrell, ResMed's CEO. Through the first half of the company's fiscal year, ResMed has posted an increase of 11% on adjusted revenue while earnings have gained 9%.
These are the companies making headlines in the middle of Friday trading:Intel INTC , AMD AMD – Intel fell 5.5 percent after the chipmaker said it expects revenue to be nearly flat compared to last year.
Stone futures rose but pared gains on news that Trump adviser Roger Stone had been arrested. Intel fell on guidance. Starbucks rose on strong earnings.
ResMed stock crashed Thursday after the medical technology firm missed quarterly sales projections by $16 million. ResMed stock closed up a fraction.
On a per-share basis, the San Diego-based company said it had net income of 86 cents. Earnings, adjusted for amortization costs and costs related to mergers and acquisitions, came to $1 per share. The ...
SAN DIEGO-- -- Year-over-year growth in revenue, gross margin, and operating profit Well-positioned for future growth through further penetration of untreated sleep apnea and expanding portfolio in respiratory care and Software as a Service Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. EST today at http://investor.resmed.com ResMed Inc. , a world-leading connected health ...
ResMed (NYSE: RMD, ASX: RMD), today introduced AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the United States, with a newly designed nasal cradle cushion that sits just under the wearer’s nose. The nasal cradle cushion – ResMed’s first – is designed to reduce facial markings and irritation. AirFit N30i is also convenient for equipment providers and sleep labs – it fits 96 percent of PAP users with just two frame sizes and four cushion sizes.
NEW YORK, Jan. 16, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
ResMed (NYSE: RMD, ASX: RMD), a leader in respiratory care medical devices and out-of-hospital care software, today announced that its premier portable oxygen concentrator, Mobi, is now widely available in the United States. Mobi offers an optimal balance of oxygen delivery, weight and battery life so that millions of people with chronic obstructive pulmonary disease (COPD) or other chronic diseases can enjoy ResMed-quality oxygen therapy wherever they go.
RADNOR, Pa., Jan. 7, 2019 /PRNewswire/ -- Safeguard Scientifics, Inc. (SFE) (Safeguard or the Company) today announced that its partner company, Propeller Health, has been acquired by ResMed (RMD) (RMD.AX) for $225 million in cash. Safeguard will receive total cash proceeds of $41.4 million, which excludes an amount of additional proceeds to be held in escrow, representing an approximate 3x cash-on-cash return and 34% IRR. "The closing of the Propeller Health acquisition by ResMed brings together two exceptional teams dedicated to improving respiratory medicine with digital technology.
ResMed (RMD) (RMD.AX), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has completed its acquisition of Propeller Health, a digital therapeutics company providing connected health solutions for people living with chronic obstructive pulmonary disease (COPD) and asthma. Propeller will continue to operate as a standalone business out of its Madison, Wisc., and San Francisco offices, working with leading pharmaceutical partners and other healthcare organizations to provide digital therapeutics and actionable insights to people who use inhalers, helping improve their medication adherence, increase their number of symptom-free days, and reduce emergency room visits.
ResMed today announced it plans to release financial and operational results for the second quarter of fiscal year 2019 on Thursday, January 24, 2019, after the New York Stock Exchange closes.
Is the stock market correction of the past three months a harbinger of an awful 2019, or a launchpad for a new bull market? While it's folly to make a stock market forecast for 2019, a few trends hold answers.